Cryosurgery News
1 news items found
-
DermBiont Announces Acquisition of SeylanMED to Expand its Portfolio of Targeted Topical Therapeutics Treating Skin Diseases at Their Root Cause
BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc. “This strategic acquisition delivers multi-factorial value,” said Karl Beutner, MD, PhD, Co-founder, CEO, and CMO of DermBiont. “It expands ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you